Editorial: Inflammation in muscular dystrophies: mediators, mechanisms, and therapeutics.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Villa C;Villa C; Farini A; Farini A; Torrente Y; Torrente Y; Torrente Y
  • Source:
    Frontiers in immunology [Front Immunol] 2024 Aug 22; Vol. 15, pp. 1470266. Date of Electronic Publication: 2024 Aug 22 (Print Publication: 2024).
  • Publication Type:
    Editorial; Introductory Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
    • Publication Information:
      Original Publication: [Lausanne : Frontiers Research Foundation]
    • Subject Terms:
      Muscular Dystrophies*/therapy ; Muscular Dystrophies*/immunology ; Inflammation*/immunology; Humans ; Animals ; Inflammation Mediators/metabolism
    • Abstract:
      Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
    • Contributed Indexing:
      Keywords: DMD; GHS (growth hormone secretagogues); NLRP3; inflammation; miRNA; muscular dystrophies
    • Accession Number:
      0 (Inflammation Mediators)
    • Publication Date:
      Date Created: 20240906 Date Completed: 20240906 Latest Revision: 20240906
    • Publication Date:
      20240906
    • Accession Number:
      PMC11374735
    • Accession Number:
      10.3389/fimmu.2024.1470266
    • Accession Number:
      39238646